Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
Condition:   COPD Asthma Interventions:   Device: Spirometry;   Drug: Albuterol Sponsors:   University of Illinois at Chicago;   Agency for Healthcare Research and Quality (AHRQ) Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2017 Category: Research Source Type: clinical trials

Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma
Condition:   Asthma Interventions:   Drug: Placebo;   Drug: Umeclidinium;   Drug: Fluticasone Furoate;   Drug: Albuterol/salbutamol Sponsor:   GlaxoSmithKline Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2017 Category: Research Source Type: clinical trials

Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma
Condition:   Asthma Interventions:   Drug: Placebo;   Drug: UMEC;   Drug: Fluticasone Furoate;   Drug: Albuterol/salbutamol Sponsor:   GlaxoSmithKline Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2017 Category: Research Source Type: clinical trials

A Study to Evaluate the Relationship Between Use of Albuterol Electronic Multidose Dry Powder Inhaler (eMDPI) and Exacerbations in Patients With Asthma
Condition:   Asthma Intervention:   Drug: ABS eMDPI Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2016 Category: Research Source Type: clinical trials

Comparison of Albuterol for Status Asthmaticus
Condition:   Status Asthmaticus Intervention:   Drug: preservative free albuterol Sponsor:   University of Louisville Active, not recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2016 Category: Research Source Type: clinical trials